603882 Guangzhou Kingmed Diagnostics Group
- 38.10
- -4.05-9.61%
Guangzhou Kingmed Diagnostics Group News
Jinyu Medical (603882.SH) announced its 2023 annual results. Net profit of 643 million yuan decreased by 76.64% year on year
Jinyu Medical (603882.SH) released the 2023 annual performance report. The company achieved operating income of 8 during the reporting period...
Jinyu Medical (603882.SH): Initial repurchase of 45,000 shares
Gelonghui, April 16, 丨 Jinyu Medical (603882.SH) announced that on April 16, 2024, the company implemented the first repurchase of the company's shares through the Shanghai Stock Exchange trading system. The company repurchased a total of 45,000 shares for the first time through centralized bidding transactions, accounting for 0.0096% of the company's current total share capital. The highest price of the repurchase transaction was 46.97 yuan/share, and the lowest price was 46.24 yuan/share. The total amount paid was RMB 2,09728.00 (excluding transaction fees and other fees).
Jinyu Medical (603882.SH): Chairman proposes to buy back the company's shares
On April 9, Ge Longhui Medical (603882.SH) announced that Mr. Leung Yiu-ming, the controlling shareholder, actual controller and chairman of the company, is based on confidence in the company's continuous development and high recognition of the company's value. In order to more effectively integrate shareholders' interests, company interests and employees' personal interests to promote the long-term, stable and sustainable development of the company, Mr. Leung Yiu-ming proposed that the company use its own funds to repurchase the company's shares through centralized bidding transactions to implement equity incentives. Total capital to be repurchased: RMB 50 million.
Zhitong A Share Sale Restriction and Release List | April 9
According to the Zhitong Finance App, the ban on restricted shares of 7 listed companies was lifted on April 9, with a total market value of about 5.471 billion yuan. Today's specific sales restrictions and unbanned shares are as follows: Stock abbreviation, stock code, number of shares unbanned, Huabei Pharmaceutical 600812 issued additional A shares, the original shareholder placed 84.256 million shares before issuance, limited sale and circulation 102 million, Jinyu Medical 603882, the original shareholders placed 3.1237 million additional A shares, the original shareholder placed and listed 3.1237 million Yingqu Technology 002925 share incentives to limit circulation 254,200 CCC Radiation 300962 shares restricted circulation before issuance 1.4
Declining Stock and Solid Fundamentals: Is The Market Wrong About Guangzhou Kingmed Diagnostics Group Co., Ltd. (SHSE:603882)?
Guangzhou Kingmed Diagnostics Group (SHSE:603882) has had a rough month with its share price down 6.7%. However, stock prices are usually driven by a company's financial performance over the long te
Jinyu Medical (603882.SH) has spent 84.748,900 yuan to buy back 1.496 million shares
Jinyu Medical (603882.SH) issued an announcement. As of March 31, 2024, the repurchase plan company...
Guoxin Securities: The pharmaceutical industry is entering an upward inflection point in the medium to long term, and focus on high growth targets in the quarterly report in the short term
The pharmaceutical industry currently has low growth, low profitability, undervaluation, and low transaction attention, and is entering a major layout range at an upward inflection point in the medium to long term.
Guolian Securities: Medical AI empowers the healthcare industry chain and focuses on companies with leading technology layout and strong commercialization capabilities
Healthcare is one of the important fields of large-scale application of artificial intelligence technology (AI).
Recent Uptick Might Appease Guangzhou Kingmed Diagnostics Group Co., Ltd. (SHSE:603882) Institutional Owners After Losing 20% Over the Past Year
Key Insights Institutions' substantial holdings in Guangzhou Kingmed Diagnostics Group implies that they have significant influence over the company's share price The top 7 shareholders own 51% of t
Jinyu Medical (603882.SH): It has repurchased a total of 1.092,600 shares at a cost of 61.44,900 yuan
Gelonghui, March 1, 丨 Jinyu Medical (603882.SH) announced that as of February 29, 2024, the company had repurchased a total of 1.0926 million shares, accounting for 0.2331% of the company's total share capital. The highest purchase price was 60.67 yuan/share, the lowest price was 51.17 yuan/share, and the total amount paid was 61.44,900 yuan (not including transaction fees, etc.).
Here's What's Concerning About Guangzhou Kingmed Diagnostics Group's (SHSE:603882) Returns On Capital
To find a multi-bagger stock, what are the underlying trends we should look for in a business? In a perfect world, we'd like to see a company investing more capital into its business and ideally the
Guangzhou Kingmed Diagnostics Group (SHSE:603882) Has A Pretty Healthy Balance Sheet
Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of permanent loss is the risk I worry about... and every practical investor I know wor
Jinyu Medical (603882.SH): As of January 31, 583,000 shares have been repurchased
Gelonghui, January 31, 丨 Jinyu Medical (603882.SH) announced that as of January 31, 2024, the company had repurchased 583,000 shares, accounting for 0.1244% of the company's total share capital. The highest purchase price was 56.27 yuan/share, the lowest price was 52.50 yuan/share, and the total amount paid was 31,630,544.26 yuan (not including transaction fees).
Jinyu Medical (603882.SH): Initial repurchase of 125,000 shares
Gelonghui, January 24, 丨 Jinyu Medical (603882.SH) announced that on January 24, 2024, the company repurchased a total of 125,000 shares of the company's shares for the first time through centralized bidding transactions, accounting for 0.0267% of the company's total share capital. The highest price of the repurchase transaction was 53.96 yuan/share, the lowest price was 52.62 yuan/share, and the total amount paid was RMB 6,688,743.78 (not including transaction fees).
Investing in Guangzhou Kingmed Diagnostics Group (SHSE:603882) Five Years Ago Would Have Delivered You a 163% Gain
It might be of some concern to shareholders to see the Guangzhou Kingmed Diagnostics Group Co., Ltd. (SHSE:603882) share price down 13% in the last month. But in stark contrast, the returns over th
Jinyu Medical (603882.SH) plans to spend 50 million to 100 million yuan to repurchase shares at a repurchase price of no more than 80 yuan/share
Jinyu Medical (603882.SH) announced that the company plans to buy back the company's shares through centralized bidding transactions for actual use...
Jinyu Medical (603882.SH): Completed the repurchase at a cost of 999.882 million yuan and actually repurchased 1.696,800 shares
Gelonghui, January 11, 丨 Jinyu Medical (603882.SH) announced that on January 11, 2024, the company completed the repurchase. The repurchase plan has actually repurchased 1.696,800 shares of the company's shares, accounting for 0.3620% of the company's total share capital. The highest repurchase price is 63.16 yuan/share, the lowest repurchase price is 53.30 yuan/share, the average repurchase price is 58.93 yuan/share, and the total capital used is 99.9882 million yuan.
Guangzhou Kingmed Diagnostics Group Co., Ltd. (SHSE:603882) Investors Are Less Pessimistic Than Expected
With a median price-to-earnings (or "P/E") ratio of close to 35x in China, you could be forgiven for feeling indifferent about Guangzhou Kingmed Diagnostics Group Co., Ltd.'s (SHSE:603882) P/E ratio
Jinyu Medical (603882.SH): A total of 647,000 shares have been repurchased
Gelonghui, January 2, 丨 Jinyu Medical (603882.SH) announced that as of December 29, 2023, the company had repurchased a total of 647,000 shares, accounting for 0.1380% of the company's total share capital. The highest purchase price was 63.16 yuan/share, the lowest price was 60.49 yuan/share, and the total amount paid was 39,991,636.28 yuan (not including transaction fees).
Zhu Shaoxing added Jinyu Medical, and Dong Chengfei joined a new semiconductor company
Since the fourth quarter, veteran public fundraiser Zhu Shaoxing has made frequent moves. Following the addition of positions at Dongfang Yuhong and Lan Xiao Technology, he has continued to step up third-party medical testing and pathological diagnosis companies. On December 22, Jinyu Medical revealed the latest list of the top ten shareholders as of December 18. Compared with the end of the third quarter, the number of shares held by Fuguo Tianhui Select, managed by Zhu Shaoxing, increased by about 500,000 shares. Combined with Jinyu Medical's average price estimates of 62 yuan/share since the fourth quarter, Zhu Shaoxing increased its position or spent about 32 million yuan. Zhu Shaoxing has added 12.2 million new shares of Jinyu Medical since the first quarter of this year. His position was slightly adjusted several times during this period, but his overall shareholding remained almost unchanged
Analysis
Price Target
No Data
